{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:52:41Z","timestamp":1793141561784,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI22\/00252"],"award-info":[{"award-number":["FI22\/00252"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01019"],"award-info":[{"award-number":["PI22\/01019"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01710"],"award-info":[{"award-number":["PI19\/01710"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI24\/00066"],"award-info":[{"award-number":["ICI24\/00066"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RICORS2040-Renal"],"award-info":[{"award-number":["RICORS2040-Renal"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajt.2025.12.283","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:19:56Z","timestamp":1767745196000},"page":"1011-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dual targeting of B cell compartments using belatacept and daratumumab in highly sensitized kidney transplant candidates: A mechanistic proof-of-concept desensitization trial"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-2313","authenticated-orcid":false,"given":"Paolo","family":"Malvezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2502-741X","authenticated-orcid":false,"given":"Anna","family":"Mart\u00ednez-Lacalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-5196","authenticated-orcid":false,"given":"Elena","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-5999","authenticated-orcid":false,"given":"Alba","family":"Torija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Imerzoukene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-923X","authenticated-orcid":false,"given":"Maria","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-5047","authenticated-orcid":false,"given":"Laura","family":"Donadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-6105","authenticated-orcid":false,"given":"Delphine","family":"Kervella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5612-9574","authenticated-orcid":false,"given":"Claudia","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3304-0810","authenticated-orcid":false,"given":"Irina B.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0423-703X","authenticated-orcid":false,"given":"Jorge Iv\u00e1n","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8431-3757","authenticated-orcid":false,"given":"Mariona","family":"Juv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1713-9012","authenticated-orcid":false,"given":"Cristina","family":"Font-Mi\u00f1arro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-0842","authenticated-orcid":false,"given":"Celine","family":"Dard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-7506","authenticated-orcid":false,"given":"Thomas","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-1485","authenticated-orcid":false,"given":"Eduard","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7267-3963","authenticated-orcid":false,"given":"Francesc","family":"Moreso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5130-7286","authenticated-orcid":false,"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-7920","authenticated-orcid":false,"given":"Oriol","family":"Bestard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajt.2025.12.283_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ckj\/sfz011","article-title":"The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary","volume":"12","author":"Kramer","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ajt.2025.12.283_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686271","article-title":"Current approaches to desensitization in solid organ transplantation","volume":"12","author":"Schinstock","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.12.283_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10511","article-title":"European guideline for the management of kidney transplant patients with HLA antibodies: by the European Society for Organ Transplantation Working Group","volume":"35","author":"Mamode","year":"2022","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.283_bib4","first-page":"998","article-title":"Outcomes of kidney transplantation in highly HLA-sensitized patients treated with intravenous immuno-globulin, plasmapheresis and rituximab: a meta-analysis","volume":"14","author":"Chandramohan","year":"2024","journal-title":"Life (Basel)"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.283_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.283_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ajt.15613","article-title":"A prospective, iterative, adaptive trial of carfilzomib-based desensitization","volume":"20","author":"Tremblay","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.283_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial","volume":"18","author":"Moreso","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.283_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ajt.15055","article-title":"Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation","volume":"19","author":"Luque","year":"2019","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.283_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.humimm.2018.09.003","article-title":"New insights into the development of B cell responses: implications for solid organ transplantation","volume":"80","author":"Chong","year":"2019","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.283_bib10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.2015.205","article-title":"Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation","volume":"88","author":"L\u00facia","year":"2015","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.283_bib11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ki.2014.390","article-title":"Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant","volume":"87","author":"Snanoudj","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.283_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocols on human splenic B-cell populations in vivo","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.283_bib13","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2016070727","article-title":"Humoral compensation after bortezomib treatment of allosensitized recipients","volume":"28","author":"Kwun","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.283_bib14","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-18-1597","article-title":"The mechanism of action of the anti-CD38 monoclonal antibody isatuximab in multiple myeloma","volume":"25","author":"Moreno","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"7","key":"10.1016\/j.ajt.2025.12.283_bib15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1681\/ASN.2018121254","article-title":"Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use","volume":"30","author":"Kwun","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.283_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1681\/ASN.0000000000000287","article-title":"Isatuximab monotherapy for desensitization in highly sensitized patients awaiting kidney transplant","volume":"35","author":"Vincenti","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.283_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajt.2024.08.004","article-title":"Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates","volume":"25","author":"Torija","year":"2025","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.283_bib18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/ajt.12350","article-title":"Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig","volume":"13","author":"Chen","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.283_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajt.12526","article-title":"Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.283_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.2017060679","article-title":"Control of humoral response in renal transplantation by belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk","volume":"29","author":"Leibler","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.283_bib21","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/ajt.14721","article-title":"De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies","volume":"18","author":"Bray","year":"2018","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.283_bib22","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/ajt.14738","article-title":"Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: post hoc analyses of BENEFIT and BENEFIT-EXT","volume":"18","author":"Bray","year":"2018","journal-title":"Am J Transplant"},{"issue":"24","key":"10.1016\/j.ajt.2025.12.283_bib23","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2017010991","article-title":"Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates","volume":"1","author":"Kwun","year":"2017","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.283_bib24","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1111\/ajt.16113","article-title":"Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition","volume":"20","author":"Alishetti","year":"2020","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.283_bib25","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/ajt.15881","article-title":"Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients","volume":"20","author":"Jain","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.283_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15249","article-title":"Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates","volume":"38","author":"Fida","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajt.2025.12.283_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2018.07.011","article-title":"A multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells","volume":"462","author":"Luque","year":"2018","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.283_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000004279","article-title":"Desensitization in crossmatch-positive kidney transplant candidates","volume":"107","author":"Noble","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.12.283_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14412","article-title":"Belatacept in kidney transplantation: reflecting on the past, shaping the future","volume":"38","author":"Noble","year":"2025","journal-title":"Transpl Int."},{"issue":"12","key":"10.1016\/j.ajt.2025.12.283_bib30","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.1097\/TP.0000000000003852","article-title":"Belatacept in kidney transplant recipients with failed allografts for the prevention of humoral sensitization: a pilot randomized controlled trial","volume":"105","author":"Badell","year":"2021","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.283_bib31","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.ekir.2024.08.020","article-title":"Open-label phase 1\/2 study of daratumumab-based desensitization before kidney transplantation","volume":"9","author":"Pilon","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.283_bib32","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2019030304","article-title":"Pretransplant Desensitization with Costimulation blockade and proteasome inhibitor reduces DSA and delays antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients","volume":"30","author":"Ezekian","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.283_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/ajt.15067","article-title":"Dual targeting: combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients","volume":"19","author":"Burghuber","year":"2019","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.283_bib34","first-page":"810","article-title":"The efficacy and safety of daratumumab-based combination therapy in multiple myeloma","volume":"33","author":"Gao","year":"2025","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.283_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003464","article-title":"Efficacy of daratumumab in refractory primary Sj\u00f6gren disease","volume":"9","author":"Nocturne","year":"2023","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.283_bib36","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3324\/haematol.2021.279232","article-title":"Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia","volume":"106","author":"Crickx","year":"2021","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.283_bib37","first-page":"415","article-title":"Persistence of HLA-DQ antibodies in transplant patients following desensitization treatment","volume":"23","author":"Yava\u015fcao\u011flu","year":"2025","journal-title":"Exp Clin Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.283_bib38","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.3324\/haematol.2019.231860","article-title":"Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients","volume":"105","author":"Frerichs","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.283_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","article-title":"CD38 antibodies in multiple myeloma: back to the future","volume":"131","author":"van de Donk","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.283_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.283_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.kint.2025.04.031","article-title":"A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated panel reactive antibody \u2265 99.9%","volume":"108","author":"Cucchiari","year":"2025","journal-title":"Kidney Int"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525034537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525034537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:56:09Z","timestamp":1784717769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525034537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1600613525034537"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.12.283","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of B cell compartments using belatacept and daratumumab in highly sensitized kidney transplant candidates: A mechanistic proof-of-concept desensitization trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.12.283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}